MADE medical AI incubation program
Genfosis selected for the MADE medical AI incubation program by AIEAT and TILSNA
Summary
Genfosis selected for the MADE medical AI incubation program by AIEAT and TILSNA
On July 28, 2026, Genfosis was named one of 44 startups selected for the Medical Artificial Intelligence Development for Entrepreneur (MADE) program, an intensive incubation initiative helping bring medical AI innovations to commercial reality.
MADE is organized by the Artificial Intelligence Entrepreneur Association of Thailand (AIEAT) together with the Technology and Innovation in Life Sciences National Agency (TILSNA), supporting HealthTech startups with technical guidance, funding pathways, and market access.
The selection marks a meaningful step for Genfosis to accelerate its work in Precision Health and Longevity, while offering the opportunity to learn and connect alongside Thailand's leading medical AI startups.
Genfosis thanks AIEAT and TILSNA for the opportunity and looks forward to helping push Thailand's HealthTech ecosystem forward.